Daniel Gehle

Dr. Daniel Gehle

Surgery, University of Tennessee Health Science Center, Memphis, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in DNA Repair
Verified
Journal Article
Closed access
JWJessica S. Williams
Jessica S. Williams
Daniel GehleDaniel Gehle
Daniel Gehle
TKThomas Kunkel
Thomas Kunkel

16 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
TPTushar P. Patel
Tushar P. Patel
JJJoo Yun Jun
Joo Yun Jun
ASArnold Y. Seo
Arnold Y. Seo
NLNoah J. Levi
Noah J. Levi
DEDiana M. Elizondo
Diana M. Elizondo
JYJack Yanovski
Jack Yanovski
Systemic lipid homeostasis requires hepatic autophagy, a major cellular program for intracellular fat recycling. Here, we find melanocortin 3 receptor (MC3R) regulates hepatic autophagy in addition to its previously established CNS role in systemic energy partitioning and puberty. Mice with Mc3r deficiency develop obesity with hepatic triglyceride accumulation and disrupted hepatocellular autophagosome turnover. Mice with partially inactive human MC3R due to obesogenic variants demonstrate similar hepatic autophagic dysfunction. In vitro and in vivo activation of hepatic MC3R upregulates autophagy through LC3II activation, TFEB cytoplasmic-to-nuclear translocation, and subsequent downstream gene activation. MC3R-deficient hepatocytes had blunted autophagosome-lysosome docking and lipid droplet clearance. Finally, the liver-specific rescue of Mc3r was sufficient to restore hepatocellular autophagy, improve hepatocyte mitochondrial function and systemic energy expenditures, reduce adipose tissue lipid accumulation, and partially restore body weight in both male and female mice. We thus report a role for MC3R in regulating hepatic autophagy and systemic adiposity.

21 September 2022 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Closed access
HMHeather McGhee
Heather McGhee
Daniel GehleDaniel Gehle
Daniel Gehle
Chelsea ShopeChelsea Shope
Chelsea Shope
CWChun-Che Wen
Chun-Che Wen
AMAlexander P Marston
Alexander P Marston
PPPhayvanh P Pecha
Phayvanh P Pecha
To describe perioperative feeding performance in infants with Robin sequence (RS) who underwent mandibular distraction osteogenesis (MDO). A retrospective study of infants that underwent MDO from May 2010 to December 2019. Tertiary pediatric hospital. A total of 40 patients underwent MDO and 20 met inclusion criteria. Of the included infants, 6 had an associated syndrome and 80% were male. Time to full oral feeds, rate of G-tube placement, and change in weight percentile following MDO. Average oral intake prior to MDO was 22.1% of individual goal feeds. Among the 15 (75%) children that did not require G-tube placement, mean time to full oral feeds after MDO was 11 days ± 5.7 days, with 80% of infants reaching full oral feeds within 2 weeks after extubation. The proportion of G-tube placement in patients with a syndrome was higher than in isolated RS (−0.6; 95% CI: −1.0, −0.2). Mean percentages of weight-for-age percentile decreased during the first 3 months after the procedure. This was followed by a mean upturn in weight starting after the third month after MDO with a recovery to preoperative mean weight-for-age percentiles by 6 months after surgery. This study suggests that infants with RS may achieve full oral feeds despite poor feeding performance before MDO. Infants with syndromic RS are more likely to require G-tube. These findings may be used to inform G-tube discussion and offer a timeline to work toward goal oral feeds for infants with RS after MDO.

1 October 2021 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
EAEmily Anderson
Emily Anderson
MGMathew J. Gregoski
Mathew J. Gregoski
Daniel GehleDaniel Gehle
Daniel Gehle
WHWilliam Taylor Head
William Taylor Head
KHKris Thomas Hardy
Kris Thomas Hardy
Rita Marie RyanRita Marie Ryan
Rita Marie Ryan

9 October 2021 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
Daniel GehleDaniel Gehle
Daniel Gehle
ACAlison Chapman
Alison Chapman
Mathew J. GregoskiMathew J. Gregoski
Mathew J. Gregoski
MBMeghan Brunswick
Meghan Brunswick
EAEmily Anderson
Emily Anderson
Rita Marie RyanRita Marie Ryan
Rita Marie Ryan

25 July 2024 in Children
Verified
Journal Article
Open access
PDF file
Daniel GehleDaniel Gehle
Daniel Gehle
ZMZach Morrison
Zach Morrison
HHHuma Faiz Halepota
Huma Faiz Halepota
AKAkshita Kumar
Akshita Kumar
CGClark Gwaltney
Clark Gwaltney
AMAndrew Murphy
Andrew Murphy
Wilms tumor (WT) is the most common kidney tumor in pediatric patients. Intravascular extension of WT above the level of the renal veins is a rare manifestation that complicates surgical management. Patients with intravascular extension are frequently asymptomatic at diagnosis, and tumor thrombus extension is usually diagnosed by imaging. Neoadjuvant chemotherapy is indicated for thrombus extension above the level of the hepatic veins and often leads to thrombus regression, obviating the need for cardiopulmonary bypass in cases of cardiac thrombus at diagnosis. In cases of tumor extension to the retrohepatic cava, neoadjuvant therapy is not strictly indicated, but it may facilitate the regression of tumor thrombi, making resection safer. Hepatic vascular isolation and cardiopulmonary bypass increase the risk of bleeding and other complications when utilized for tumor thrombectomy. Fortunately, WT patients with vena caval with or with intracardiac extension have similar overall and event-free survival when compared to patients with WT without intravascular extension when thrombectomy is successfully performed. Still, patients with metastatic disease at presentation or unfavorable histology suffer relatively poor outcomes. Dedicated pediatric surgical oncology and pediatric cardiothoracic surgery teams, in conjunction with multimodal therapy directed by a multidisciplinary team, are preferred for optimized outcomes in this patient population.